Literature DB >> 15017220

Urinary conduit formation using a retubularized bowel from continent urinary diversion or intestinal augmentations: ii. Does it have a role in patients with interstitial cystitis?

Ahmed Elzawahri1, Nabil K Bissada, Sender Herchorn, Hassan Aboul-Enein, Mohamed Ghoneim, Mary A Bissada, Alex Finkbeiner, A A Glazer.   

Abstract

PURPOSE: Interstitial cystitis (IC) may require surgical treatment in a minority of patients in whom conservative treatment failed. This treatment includes enterocystoplasty (ECP), or continent or incontinent urinary diversion with or without cystourethrectomy. Patients with IC who underwent ECP or continent urinary diversion (CUD) occasionally have recurrent pain in the augmented bladder or continent pouch. In these patients a new ileal conduit is frequently constructed. Using part of the continent urinary diversion or bladder augmentation patch to make the ileal conduit has been reported. However, there may be some concern with performing the procedure in patients with IC because of the theoretical risk of continued pain in the converted ileal segment. We evaluated the role of conduit formation using retubularized bowel from ECP or CUD in patients with IC.
MATERIALS AND METHODS: A total of 11 patients with a mean age of 45 years underwent conduit formation using the augmentation patch of ECP or part of the continent urinary reservoir. Patients were followed by history, physical examination, laboratory tests and urography.
RESULTS: Followup was 20 to 80 months. One patient continued to have pelvic pain. None of the patients had residual pain in the conduit. One patient had intermittent pain in the conduit 32 months after conversion. Two patients had ureteral obstruction requiring ureteral reimplantation revision. No patient complained of new gastrointestinal problems.
CONCLUSIONS: Retubularization of a previously used bowel segment from ECP or CUD to form a urinary conduit seems to be an acceptable alternative in patients with IC.

Entities:  

Mesh:

Year:  2004        PMID: 15017220     DOI: 10.1097/01.ju.0000116772.74358.39

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

Review 1.  Indications for Augmentation Cystoplasty in the Era of OnabotulinumtoxinA.

Authors:  Evan Shreck; Kevin Gioia; Alvaro Lucioni
Journal:  Curr Urol Rep       Date:  2016-04       Impact factor: 3.092

2.  Retubularization of the ileocystoplasty patch for conversion into an ileal conduit.

Authors:  Peter A Massaro; Jerzy B Gajewski; Greg Bailly
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

3.  Augmentation cystoplasty: Contemporary indications, techniques and complications.

Authors:  Rajan Veeratterapillay; Andrew C Thorpe; Chris Harding
Journal:  Indian J Urol       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.